Tweet

Feline Stomatitis Data To Be Presented At Veterinary Dental Forum

Author: Imulan
Posted: Thursday 22nd October, 2009. 00:00:00

Imulan BioTherapeutics, LLC (IMULAN) has been selected to present their most recent findings on feline stomatitis at this year’s Veterinary Dental Forum. The session entitled “T-Cell Receptor Peptide Technology for Feline Stomatitis” will be presented by Dr. Craig Woods. The T-Cell Receptor (TCR) technology, a biologic immune modulator, is being developed by IMULAN for immune based disorders including stomatitis. Feline stomatitis, often referred to as lymphocytic plasmacytic stomatitis or gingivostomatitis, is a disorder that results in oral inflammation. The TCR technology affects T-helper cells, which are immune cells implicated in feline stomatitis.

About Feline Stomatitis Feline stomatitis is a frustrating and prevalent condition in cats. Although there is no known single cause of this condition, the outcome is inflammation of the oral cavity and gingival tissue. The inflammation is a result of immune cells infiltrating the tissue and is thought to be an imbalance in a specific type of lymphocyte, called the T-helper cell. Treatment for feline stomatitis is often limited and may consist of steroids, antibiotics, anti-inflammatories, and/or surgery.

About the TCR peptides T-Cell Receptor peptides are immune modulating biologics designed to restore immune function and normalize cytokine profiles by precisely regulating T-helper cell activity. The peptides are undergoing evaluation for atopic dermatitis, feline stomatitis, and various other disorders including viral infections, cardiac disease, and fungal infections.

This article has been viewed 1141 times.

 

Comments about this article